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Abstract
Background: Psychosocial stress is a risk factor for coronary heart disease (CHD). The mechanisms are incompletely
understood, although dysfunction of the hypothalamic pituitary adrenal (HPA) axis might be involved. We examined the
association between cortisol responses to laboratory-induced mental stress and the progression of coronary artery
calcification (CAC).
Methods and Results: Participants were 466 healthy men and women (mean age= 62.765.6 yrs), without history or
objective signs of CHD, drawn from the Whitehall II epidemiological cohort. At the baseline assessment salivary cortisol was
measured in response to mental stressors, consisting of a 5-min Stroop task and a 5-min mirror tracing task. CAC was
measured at baseline and at 3 years follow up using electron beam computed tomography. CAC progression was defined as
an increase .10 Agatston units between baseline and follow up. 38.2% of the sample demonstrated CAC progression over
the 3 years follow up. There was considerable variation in the cortisol stress response, with approximately 40% of the
sample responding to the stress tasks with an increase in cortisol of at least 1 mmol/l. There was an association between
cortisol stress reactivity (per SD) and CAC progression (odds ratio = 1.27, 95% CI, 1.02–1.60) after adjustments for age, sex,
pre-stress cortisol, employment grade, smoking, resting systolic BP, fibrinogen, body mass index, and use of statins. There
was no association between systolic blood pressure reactivity and CAC progression (odds ratio per SD increase = 1.03, 95%
CI, 0.85–1.24). Other independent predictors of CAC progression included age, male sex, smoking, resting systolic blood
pressure, and fibrinogen.
Conclusion: Results demonstrate an association between heightened cortisol reactivity to stress and CAC progression.
These data support the notion that cortisol reactivity, an index of HPA function, is one of the possible mechanisms through
which psychosocial stress may influence the risk of CHD.
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Introduction
The accumulating evidence that stress-related factors contribute
to the development of cardiovascular disease (CVD) has stimulated
research into the underlying pathways involved [1]. Psychophys-
iological stress testing can be used to better understand the
mechanisms underlying the association between mental stress and
CVD [2]. Existing work has largely focused on cardiovascular
reactivity to stress as a tool to predict future risk, and the
associations are modest but consistent [3]. The issue of whether
stress reactivity contributes to the progression of underlying disease
or only to the incidence of clinical cardiac events has led to
research involving indicators of subclinical disease. For example,
in 756 men from the Kuopio Ischemic Heart Disease study,
systolic BP reactivity at the baseline assessment was related to
carotid intima media thickness (IMT) after seven years follow up
and also to the progression of IMT, independently of established
risk factors [4]. Two separate studies in healthy women showed
that cross-sectionally, greater pulse pressure and systolic BP
reactivity were respectively associated with greater carotid IMT
[5] and the presence of coronary artery calcium (CAC) [6].
The importance of stress reactivity in other biological pathways
relevant to CVD risk has gained less attention. Abnormalities in
hypothalamic pituitary adrenal (HPA) function have been
described in several chronic inflammatory disorders, and may
be a possible mechanisms through which psychosocial stress
influences the risk of CVD [7,8]. In a cross-sectional study
containing healthy participants from the Whitehall II cohort we
recently demonstrated an association between cortisol stress
reactivity and subclinical coronary disease as indexed by CAC
[9]. Since the interpretation of cross-sectional data can be
problematic, we performed a prospective follow up of this study
to examine the association between cortisol stress reactivity and
CAC progression.
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Materials and Methods
Participants
A sample of participants was drawn from the Whitehall II
epidemiological cohort [10] for psychophysiological testing during
2006 to 2008 (baseline) and underwent scans at baseline and three
years follow up to measure CAC progression. The criteria for
entry into the study included no history or objective signs of CHD,
no previous diagnosis or treatment for hypertension, inflammatory
diseases, or allergies. Volunteers were of white European origin,
aged 53–76 years, and 56.5% were in full-time employment.
Selection was stratified by grade of employment (current or most
recent) to include higher and lower socioeconomic status
participants. Participants were prohibited from using any anti-
histamine or anti-inflammatory medication 7 days before testing
and were rescheduled if they reported colds or other infections on
the day of testing. Participants gave full written informed consent
to participate in the study and ethical approval was obtained from
the UCLH committee on the Ethics of Human Research.
Psychophysiological testing at baseline
Testing was performed in either the morning or afternoon in a
light temperature-controlled laboratory, and was based on a
protocol previously used in this laboratory [11]. Participants were
instructed to refrain from drinking caffeinated beverages or
smoking for at least 2 hours before the study and not to have
performed vigorous physical activity or consumed alcohol the
previous evening. After a 30 minute rest period baseline blood
pressure (using an automated UA-779 digital monitor) and a saliva
sample were taken. Two behavioral tasks, designed to induce
mental stress, were then administered in a random order. The
tasks were a computerized version of the Stroop task and mirror
tracing, both of which have been used extensively in psychophys-
iological research [12]. The tasks each lasted for 5 minutes.
Participants then rested for 75 minutes. Blood pressure measure-
ments were continuously assessed throughout the protocol, using a
Finometer device (Finapres Medical Systems, Amsterdam). Blood
pressure reactivity was calculated from a pre-stress baseline period
(average over 5 minutes) and mean blood pressure during the
stressors aggregated across tasks. Saliva samples were collected
immediately following the tasks and then at 20, 45, and
75 minutes post stress for the assessment of salivary cortisol. The
samples were collected using Salivettes (Sarsted, Leicester, UK),
which were stored at 230uC until analysis. Levels of cortisol were
assessed using a time resolved immuno-assay with fluorescence
detection, at the University of Dresden. The intra and inter-assay
coefficients of variation were ,8%. Peak responses in cortisol
tended to occur immediately after the tasks, thus for the purposes
of the present study samples at pre-stress and immediately
following the tasks was used to calculate a stress response change
score [Cort change =Cortpost stress2Cortpre-stress].
Coronary artery calcification (baseline and follow up)
The assessment of CAC was performed at baseline and three
years follow up using electron beam computed tomography (GE
Imatron C-150, San Francisco, CA) as previously described [13].
In brief, 40 contiguous 3-mm slices were obtained during a single
breath-hold starting at the carina and proceeding to the level of
the diaphragm. Scan time was 100 ms/slice, synchronized to 40%
of the R-R interval. Agatston and volumetric calcium scores were
calculated to quantify the extent of CAC by a single experienced
investigator blinded to the psychophysiological and clinical data
on an Aquarius workstation (TeraRecon Inc., San Mateo, CA).
Since calcified volume was very highly correlated with Agatston
score (Spearman’s r = 0.99), we present data for Agatston score
only.
Covariates
Participants reported current smoking levels. Height and weight
were recorded in light clothing for the calculation of body mass
index (BMI). Fasting blood samples were taken during a separate
clinical assessment. Analysis of C-reactive protein (CRP) and
fibrinogen was performed using high-sensitivity ELISA (R & D
Systems, Oxford, UK). Total and high-density-lipoprotein (HDL)
cholesterol and triglycerides was measured within 72 h in serum
stored at 4uC using enzymatic colorimetric methods. Low-density-
lipoprotein (LDL) cholesterol was derived using the Friedewald
equation. Glucose homeostasis was assessed from glycated
haemoglobin (HbA1C) concentration, assayed using boronate
affinity chromatography, a combination of boronate affinity and
liquid chromatography.
Statistical analysis
We defined progression of CAC in two ways. Firstly, as a binary
variable defined as change in Agatston score .10, a cut off
previously used to assess significant progression in an asymptom-
atic population [14]. Secondly, in order to perform linear analysis
we used a previously described formula [15], which expresses
relative change in CAC as the change from baseline to follow in the
log of CAC plus a constant [ln(CACfup+25)2ln(CACbaseline+25)].
This approach has advantages over using percentage changes
that are influenced by very small baseline CAC values for which a
very small absolute increase can result in large percentage
changes. The use of the log-scale also de-emphasizes very large
follow-up CAC scores. Associations between cortisol reactivity (per
SD change) and CAC progression were investigated using both
logistic and linear regression, adjusting for age, gender, follow up
time, pre-stress cortisol level, employment grade, use of statins,
resting blood pressure, fibrinogen, HDL and LDL cholesterol,
body mass index, and smoking. Associations between blood
pressure reactivity and CAC progression were also performed
using the approaches described above. All analyses were
conducted using SPSS version 15.
Results
At baseline 496 participants had complete data on cortisol,
CAC, and all covariates. Thirty participants did not complete
follow up (3 deceased, 7 lost to follow up, 20 declined), thus the
analytic sample comprised 466 participants (mean age= 62.76
5.6 yrs; range, 53–76 yrs). Participants that did not complete
follow up were slightly older than those that remained in the study
(65.3 vs. 62.7 yrs, p = 0.01), although there was no difference in
levels of baseline CAC (% without detectable CAC; 33.3 vs.
44.3%, p= 0.22). The average follow up period was 2.98 yrs,
ranging from 1.75–3.55 yrs.
Among participants with no detectable CAC at baseline
(n = 215, 44.3% of sample), 50 of them developed new incident
CAC during the 3 year follow up (see Figure 1). In the overall
sample there was a significant increase in log Agatston score
between baseline and follow up (2.25 vs 2.65, p,0.001), and
38.2% had progression of CAC as defined by an increase in .10
Agatston units. Participants with CAC progression .10 units were
older, more likely to be male, smokers, statin users, have higher
blood pressure, lower HDL cholesterol, and higher fibrinogen
levels compared to participants without CAC progression
(Table 1).
Cortisol and CAC Progression
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There was considerable variation in the cortisol stress response,
with approximately 40% of the sample responding to the stress
tasks with an increase in cortisol of at least 1 mmol/l [9]. In
analysis adjusted for age and sex, the cortisol stress response (per
SD increase) was associated with CAC progression (odds
ratio = 1.26, 95% CI, 1.02–1.52). In further models the association
remained unaltered (odds ratio = 1.27, 95% CI, 1.02–1.60) after
additional adjustments for follow up time, pre-stress cortisol level,
employment grade, use of statins, resting blood pressure,
fibrinogen, HDL and LDL cholesterol, body mass index, and
smoking. Other independent predictors of CAC progression
included age, male sex, smoking, systolic blood pressure, and
fibrinogen (Table 2).
We also performed linear analyses to examine the associations
between cortisol and relative CAC change. In these analyses, CAC
change was associated with age, male sex, systolic BP, fibrinogen,
and cortisol reactivity (Table 3). In further multivariate models,
including adjustments for age, sex, pre-stress cortisol, employment
grade, smoking, resting systolic BP, fibrinogen, lipids, body mass
index, and use of statins, the association of cortisol reactivity was
marginally attenuated but remained independently associated with
relative change in CAC (B=0.011, 95% CI, 20.001–0.023,
p= 0.066). In analyses stratified by the presence of CAC at baseline,
the association between cortisol response and CAC change was only
evident in participants without detectable CAC at baseline (fully
adjusted B=0.017, 95% CI, 0.006–0.027, p= 0.002).
Figure 1. The progression of CAC over 3 years follow up (n=466). Filled bars designate CAC scores at follow up. Coronary artery calcification
scores of 100–400, 400–999, and $1000 predict up to 4-, 7-, and 11-fold increases in future CVD risk, respectively, compared with patients with no
detectable CAC. There was a significant increase in log Agatston score between baseline and follow up (2.25 vs 2.65, p,0.001), and 38.2% had
progression of CAC as defined by an increase in .10 Agatston units.
doi:10.1371/journal.pone.0031356.g001
Table 1. Characteristics of the study population at baseline in relation to CAC progression (N= 466).
Variable No progression (N=288) CAC progression* (N=178) p-value
Age (yrs) 62.365.3 63.365.9 0.046
Men (%) 135 (46.9) 118(66.3) ,0.001
Highest work grade (%) 116 (40.3) 73 (41.0) 0.88
Current smokers (%) 11 (3.8) 14 (7.9) 0.06
Resting systolic BP (mmHg) 121.3616.5 126.8615.7 ,0.001
HDL cholesterol (mmol/l) 1.7460.48 1.6260.44 0.01
LDL cholesterol (mmol/l) 3.8960.96 3.9460.91 0.56
C-reactive protein (mg/l) 1.5962.07 1.6062.07 0.94
Fibrinogen (g/l) 3.0860.59 3.2660.62 0.002
Body mass index (kg/m2) 25.764.2 26.163.6 0.29
HbA1c (%) 5.4660.39 5.4460.38 0.62
Pre-stress cortisol (mmol/l) 6.5864.29 6.5264.81 0.88
Statins use (%) 21 (7.3) 22 (12.4) 0.07
Mean follow up (days) 1081681 1104674 0.003
*CAC progression defined as an increase .10 Agatston units between baseline and follow up.
Values are means 6 SD.
doi:10.1371/journal.pone.0031356.t001
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On average, systolic blood pressure increased by
30.8615.1 mmHg (range=26.1 to 85.3 mmHg) in response to
the stress tasks, and there was a significant correlation between
cortisol stress reactivity and systolic blood pressure reactivity
(Pearson r=0.15, p= 0.001). However, systolic blood pressure
reactivity was not associated with CAC progression (age and sex
adjusted odds ratio per SD increase = 1.03, 95% CI, 0.85–1.24),
and neither was diastolic blood pressure reactivity (age and sex
adjusted odds ratio per SD increase = 0.96, 95% CI, 0.80–1.16).
Systolic blood pressure reactivity was similar in participants with
and without detectable CAC at baseline, respectively (31.8615.8
vs. 30.2614.2 mmHg, p= 0.43), and also similar in those who did
and did not have CAC progression (31.5615.8 vs.
30.2614.6 mmHg, p= 0.34).
Discussion
Previous data have shown associations between heightened
cardiovascular reactivity and future CVD risk, although the utility
of biological stress responses in predicting risk have not been
adequately examined. The aim of this study was to investigate the
association between cortisol stress reactivity and the progression of
sub-clinical coronary atherosclerosis in healthy men and women.
We observed an association between cortisol reactivity and CAC
progression, with a 27% increase in the odds of progression per
SD change in cortisol responsivity. These associations were largely
independent of conventional risk factors. This relationship was
most evident in participants without detectable CAC at baseline,
which further supports the notion that heightened cortisol
reactivity might be important in the aetiology of atherosclerosis
and is not simply a marker of disease progression. Indeed, the
development of new incident CAC reflects a different stage of the
disease process compared with increases in existing calcification.
To our knowledge, this is the first study to show a prospective
association between cortisol stress reactivity and progression of sub-
clinical atherosclerosis. Other studies have examined associations
between sympathetic nervous activity and various CVD risk factors.
For example, in a small prospective study conducted on Norwegian
military personal, norepinephrine responses to mental stress and
cold pressor at the baseline examination was associated with insulin
resistance and blood pressure at the 18 year follow up assessment
[16,17]. Several population studies have demonstrated associations
between diurnal cortisol patterns and CVD; Dekker et al [18]
observed an association between total cortisol exposure while awake
and higher carotid plaque scores in a sample of older adults, whilst
another study showed a greater presence of CAC in younger
participants with a flatter diurnal cortisol decline [19]. Also, a flatter
slope in cortisol levels across the day was associated with an
increased risk of CVD mortality in British civil servants [20], and
24 hr urinary cortisol was associated with CVD death in the
InCHIANTI prospective cohort study of older participants [21].
Several studies have also linked raised cortisol levels with metabolic
risk factors, including fasting glucose, lipids, and obesity [22,23].
The findings from clinical patient groups are less clear. Low serum
cortisol levels were shown to predict death following myocardial
infarction [24] and reduced cortisol stress responses in patients with
stable CAD have also been observed [25]. In contrast, elevated
fasting cortisol was associated with risk of future cardiac events in
patients with chronic heart failure [26,27]. Interestingly, in our
study CAC progression was unrelated to resting cortisol levels or
total cortisol production (area under the curve) over the psycho-
physiological testing period. The equivocal nature of some of these
findings might be related to the strong diurnal cortisol pattern that
can heavily influence the results. Therefore, single measures of
cortisol might not be appropriate to capture the dynamic nature of
HPA activity. In this regard, psychophysiological testing is
advantageous since extrinsic factors can be tightly controlled.
Previous work has demonstrated that heightened blood pressure
responses to laboratory induced stressors is associated with CVD
risk, such as progression of IMT and hypertension [3,4]. In a young,
healthy sample of women, aged 20 to 35 years at baseline, each
10 mm Hg change in systolic blood pressure during a video game
stressor was associated with a 24% increased odds of having CAC
after 13 years follow-up, although there was no association with
blood pressure reactivity during a star tracing task [6]. Thus, our
null findings on blood pressure responses and CAC are inconsistent
Table 2. Risk factors for CAC progression of .10 Agatston
units (N = 466).
Risk factor Odds Ratio (95% CI)*
Age (per yr) 1.05 (1.01–1.10)
Male sex 2.11 (1.23–3.63)
Cortisol stress response{ 1.27 (1.02–1.60)
Resting Systolic BP{ 1.25 (1.01–1.56)
Fibrinogen{ 1.47 (1.20–1.81)
Smoking 2.50 (1.06–5.89)
LDL cholesterol{ 1.02 (0.82–1.28)
HDL cholesterol{ 0.76 (0.45–1.29)
C-Reactive protein{ 0.99 (0.89–1.10)
Body mass index{ 1.02 (0.82–1.28)
HbA1c{ 0.86 (0.49–1.48)
Statins use 1.50 (0.76–2.96)
*Effect estimates are mutually adjusted for all presented variables and follow up
time.
{per SD increase.
doi:10.1371/journal.pone.0031356.t002
Table 3. Risk factors for relative CAC changes over follow up
(N= 466).
Risk factor Coefficient* (95% CI) P-value
Age 0.005 (0.00–0.01) 0.035
Male sex 0.060 (0.007–0.113) 0.026
Resting Systolic BP{ 0.036 (0.009–0.062) 0.009
LDL cholesterol{ 0.005 (20.021–0.032) 0.724
HDL cholesterol{ 20.002 (20.030–0.027) 0.901
C-Reactive protein{ 20.005 (20.031–0.021) 0.716
Fibrinogen{ 0.040 (0.014–0.067) 0.003
Body mass index{ 0.009 (20.018–0.035) 0.515
HbA1c{ 20.017 (20.044–0.010) 0.214
Statins use 0.013 (20.078–0.105) 0.775
Pre-stress cortisol 20.001 (20.007–0.005) 0.782
Cortisol reactivity{ 0.010 (0.000–0.021) 0.049
Cortisol AUC 20.002 (20.028–0.025) 0.902
*Effect estimates are adjusted for age and sex.
{per SD increase.
BP – Blood pressure; HbA1c - glycated haemoglobin; AUC - Area under the
curve.
doi:10.1371/journal.pone.0031356.t003
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with some previous work in this area. Nevertheless, our sample was
considerably older than in many previous studies that might partly
account for the findings. In addition, previous blood pressure
reactivity studies have only collected CAC measures at one point in
time and were thus unable to examine CAC progression. Taken
together, the different effects of blood pressure and cortisol reactivity
on CAC progression shown here highlight the importance of
examining both cardiovascular and neuroendocrine indices of stress
reactivity in psychophysiological studies.
Relatively few studies have examined risk factors for the
progression of CAC. In one of the largest to date, 5756 participants
from the Multi-Ethnic Study of Atherosclerosis (MESA) were
followed up over 2 years, and results showed that most traditional
CVD risk factors were associated with both the risk of developing
new incident CAC and increases in existing calcification [15].
However, low and high density lipoprotein cholesterol was only
predictive of new incident CAC in MESA. These findings might
partly reflect differences in the definition of CAC progression. For
example, in the present study LDL cholesterol was the only risk
factor associated with new incident CAC (data not shown), although
cortisol, smoking, blood pressure and fibrinogen were associated
CAC progression when defined as an increase of .10 Agatston
units. This might also reflect differences in the mechanisms involved
at various stages of the atherosclerotic process.
The mechanisms by which HPA activity directly influences
atherosclerosis remain poorly understood, although there is some
evidence that increased circulating cortisol levels may promote
perivascular inflammation [28], and treatment with glucocorticoids
has been shown to enhance calcification within arteriosclerotic
lesions [29]. A previous study in healthy participants demonstrated
that mental stress-induced endothelial dysfunction and baroreflex
impairment was prevented by blocking cortisol production with
metyrapone [30]. Thus, heightened cortisol responses may to some
extent drive changes in hemodynamic function. Others have
reported reduced cortisol stress responses in patients with stable
CAD, and suggested that cortisol might act as a powerful anti-
inflammatory agent in preventing atherosclerotic processes [8,25].
In the present study, however, we did not observe any associations
between cortisol reactivity and markers of inflammation as indexed
by C-reactive protein [9]. We cannot, however, rule out the role of
unmeasured confounding risk factors or genetic influences that
might account for cortisol response patterns [31] and CHD risk
[32]. For example, recent evidence suggests that a common
glucocorticoid receptor polymorphism is related to higher pro-
inflammatory activity and greater risk of CHD [32].
The present study has a number of strengths and limitations.
The major strength is the prospective design of the study that
allows greater confidence in interpreting the directionality of the
observed relationships. The findings add to the evidence that
stress-related processes are associated not only with the occurrence
of clinical CVD, but also with progression of underlying coronary
disease development. It should be noted that there was a large
amount of variability in individual responses to the stressors, and
only 40% of participants in this study were defined as cortisol
responders, which is consistent with our previous findings from
another sample tested with the same behavioural tasks [33].
Cortisol responses to stress tend to be greater when participants
are confronted by social-evaluative challenges, rather than
psychomotor and problem-solving tasks of the type used here.
Cortisol stress responses were measured on a single occasion, and
there may be adaptation on repeated testing, although we have
previously demonstrated strong reproducibility of these responses
over two repeated stress sessions [34].
In conclusion, we have demonstrated a prospective association
between cortisol responses to laboratory-induced mental stress and
CAC progression. These findings provide support for the hypothesis
that hyper-reactivity of the HPA axis is one of the mechanisms
through which psychosocial stress may influence the risk of CHD.
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